Showing 581-590 of 6764 results for "".
How Much Are You Leaving on the Table?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-leaving-on-the-table/21444/How to improve your after-tax financial efficiency for 2014.The Logistics of Biologics
https://practicaldermatology.com/topics/psoriasis/the-logistics-of-biologics/22932/The road from prescription to administering biologic agents may not always be smooth, but these clinical and practical tips will help to expedite the process.Severe Urticaria After 755-nm Alexandrite Laser Surgery for Hair Reduction
https://practicaldermatology.com/topics/general-topics/severe-urticaria-after-755-nm-alexandrite-laser-surgery-for-hair-reduction/21557/A Guide to Building Lifelong Patient Loyalty
https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/Interest in medical aesthetic treatments continues to grow and signs indicate that demand will remain strong. Today’s patients are more informed and educated than ever and are seeking personalized, high-quality experiences.Dr. DiAnne Davis on Mentorship, Lasers, Skin of Color, and More
https://practicaldermatology.com/issues/september-2025/dr-dianne-davis-on-mentorship-lasers-skin-of-color-and-more/37643/In a recent YoungMD Connect virtual mentorship session, DiAnne Davis, MD, FAAD, a dermatologist based in Dallas, discussed her journey from patient to dermatologist, the influence of mentorship, and her commitment to advancing safe, effective cosmetic procedures for patients with skin of color.Lead from Ahead (For a Change)
https://practicaldermatology.com/topics/practice-management/lead-from-ahead-for-a-change/23973/Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-3/23917/Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Viewpoints : Too Many People with Dermatologic Diseases Are Excluded from Drug Innovation. Let’s Change Thathttps://practicaldermatology.com/topics/psoriasis/iviewpointsi-too-many-people-with-dermatologic-diseases-are-excluded-from-drug-innovation-lets-change-that/23713/Loyal to Whose Fault?
https://practicaldermatology.com/topics/practice-management/loyal-to-whose-fault/23584/